Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 6/20 | 0.64 |
| ▸ | NMBR | P28336 | 5/20 | 0.63 |
| ▸ | BMP1 | P13497 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7255942 | 0.97 | BRS3 (0.65) | BRS3NMBRBMP1 | |
| SCHEMBL7257081 | 0.96 | NMBR (0.64) | BRS3NMBRBMP1 | |
| SCHEMBL7256825 | 0.93 | BMP1 (0.63) | BRS3NMBRBMP1 | |
| SCHEMBL7253751 | 0.93 | BRS3 (0.72) | BRS3NMBR | |
| Hydrochloric Acid SCHEMBL7251808 | 0.93 | BMP1 (0.62) | BRS3NMBRBMP1 | |
| SCHEMBL7135018 | 0.89 | MMP1 (0.63) | BRS3NMBRBMP1 | |
| SCHEMBL7135014 | 0.89 | MMP1 (0.63) | BRS3NMBRBMP1 | |
| SCHEMBL7256838 | 0.88 | NMBR (0.71) | BRS3NMBR | |
| SCHEMBL1233776 | 0.88 | BMP1 (0.68) | BRS3NMBRBMP1 | |
| SCHEMBL7250838 | 0.87 | TRPV1 (0.61) | BRS3NMBRBMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030195212-A1 | Novel melanocortin receptor agonists and antagonists | MELACURE THERAPEUTICS AB (SE) | 2003-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195212-A1 | Novel melanocortin receptor agonists and antagonists | MC1R, MC5R, MC4R | BRS3 160/4885NMBR 264/4885BMP1 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.